{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:08:44Z","timestamp":1793837324329,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["F.No.54\/08\/2022-HUM\/BUS"],"award-info":[{"award-number":["F.No.54\/08\/2022-HUM\/BUS"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03747-x","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T07:01:57Z","timestamp":1709622117000},"page":"363-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High carrier frequency of CYP21A2 gene mutations in Southern India \u2013 underscoring the need for genetic testing in Congenital Adrenal Hyperplasia"],"prefix":"10.1007","volume":"85","author":[{"given":"Lavanya","family":"Ravichandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriti","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"HS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Danda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-6041","authenticated-orcid":false,"given":"Aaron","family":"Chapla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"key":"3747_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"H.L. Claahsen-van der Grinten, P.W. Speiser, S.F. Ahmed et al. Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management. Endocr. Rev. 43, 91\u2013159 (2022). https:\/\/doi.org\/10.1210\/endrev\/bnab016","journal-title":"Endocr. Rev."},{"key":"3747_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/edrv.21.3.0398","volume":"21","author":"PC White","year":"2000","unstructured":"P.C. White, P.W. Speiser, Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency*. Endocr. Rev. 21, 245\u2013291 (2000). https:\/\/doi.org\/10.1210\/edrv.21.3.0398","journal-title":"Endocr. Rev."},{"key":"3747_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ecl.2017.01.008","volume":"46","author":"F Hannah-Shmouni","year":"2017","unstructured":"F. Hannah-Shmouni, W. Chen, D.P. Merke, Genetics of Congenital Adrenal Hyperplasia. Endocrinol. Metab. Clin. North Am. 46, 435\u2013458 (2017). https:\/\/doi.org\/10.1016\/j.ecl.2017.01.008","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"3747_CR4","unstructured":"M. Yau, A. Khattab, T. Yuen, M. New, Congenital Adrenal Hyperplasia. In: K.R. Feingold, B. Anawalt, M.R. Blackman M.R., et al. (eds) Endotext. (MDText.com, Inc., South Dartmouth (MA), 2000)"},{"key":"3747_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/ijns6030067","volume":"6","author":"PK Held","year":"2020","unstructured":"P.K. Held, I.M. Bird, N.L. Heather, Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy. Int J. Neonatal Screen 6, 67 (2020). https:\/\/doi.org\/10.3390\/ijns6030067","journal-title":"Int J. Neonatal Screen"},{"key":"3747_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ijns6030070","volume":"6","author":"A Dabas","year":"2020","unstructured":"A. Dabas, M. Bothra, S. Kapoor, CAH Newborn Screening in India: Challenges and Opportunities. Int J. Neonatal Screen 6, 70 (2020). https:\/\/doi.org\/10.3390\/ijns6030070","journal-title":"Int J. Neonatal Screen"},{"key":"3747_CR7","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"P.W. Speiser, W. Arlt, R.J. Auchus et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 103, 4043\u20134088 (2018). https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3747_CR8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"D.P. Merke, R.J. Auchus, Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. N. Engl. J. Med. 383, 1248\u20131261 (2020). https:\/\/doi.org\/10.1056\/NEJMra1909786","journal-title":"N. Engl. J. Med."},{"key":"3747_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s12098-018-2645-9","volume":"85","author":"ICMR Task Force on Inherited Metabolic Disorders","year":"2018","unstructured":"ICMR Task Force on Inherited Metabolic Disorders, Newborn Screening for Congenital Hypothyroidism and Congenital Adrenal Hyperplasia. Indian J. Pediatr. 85, 935\u2013940 (2018). https:\/\/doi.org\/10.1007\/s12098-018-2645-9","journal-title":"Indian J. Pediatr."},{"key":"3747_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1177\/09720634211050458","volume":"23","author":"S Acharya","year":"2021","unstructured":"S. Acharya, H. Sahoo, Consanguineous Marriages in India: Prevalence and Determinants. J. Health Manag. 23, 631\u2013648 (2021). https:\/\/doi.org\/10.1177\/09720634211050458","journal-title":"J. Health Manag."},{"key":"3747_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104369","volume":"64","author":"L Ravichandran","year":"2021","unstructured":"L. Ravichandran, S. Korula, H.S. Asha et al. Allele-specific PCR and Next-generation sequencing based genetic screening for Congenital Adrenal Hyperplasia in India. Eur. J. Med. Genet. 64, 104369 (2021). https:\/\/doi.org\/10.1016\/j.ejmg.2021.104369","journal-title":"Eur. J. Med. Genet."},{"key":"3747_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2022.101748","volume":"9","author":"L Ravichandran","year":"2022","unstructured":"L. Ravichandran, D. Varghese, R. Parthiban et al. Allele-specific and multiplex PCR based tools for cost-effective and comprehensive genetic testing in Congenital Adrenal Hyperplasia. MethodsX 9, 101748 (2022). https:\/\/doi.org\/10.1016\/j.mex.2022.101748","journal-title":"MethodsX"},{"key":"3747_CR13","first-page":"866","volume":"81","author":"SY Pang","year":"1988","unstructured":"S.Y. Pang, M.A. Wallace, L. Hofman et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81, 866\u2013874 (1988)","journal-title":"Pediatrics"},{"key":"3747_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1096-8628(19980401)76:4<337::AID-AJMG9>3.0.CO;2-M","volume":"76","author":"SF Witchel","year":"1998","unstructured":"S.F. Witchel, P.A. Lee, Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests. Am. J. Med. Genet. 76, 337\u2013342 (1998)","journal-title":"Am. J. Med. Genet."},{"key":"3747_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s0015-0282(99)00317-9","volume":"72","author":"HF Escobar-Morreale","year":"1999","unstructured":"H.F. Escobar-Morreale, J.L. San Mill\u00e1n, R.R. Smith et al. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil. Steril. 72, 629\u2013638 (1999). https:\/\/doi.org\/10.1016\/s0015-0282(99)00317-9","journal-title":"Fertil. Steril."},{"key":"3747_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1530\/eje.0.1410132","volume":"141","author":"V Dolzan","year":"1999","unstructured":"V. Dolzan, J. Prezelj, B. Vidan-Jeras, K. Breskvar, Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status. Eur. J. Endocrinol. 141, 132\u2013139 (1999). https:\/\/doi.org\/10.1530\/eje.0.1410132","journal-title":"Eur. J. Endocrinol."},{"key":"3747_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1210\/jcem.85.2.6367","volume":"85","author":"HH Lee","year":"2000","unstructured":"H.H. Lee, J.M. Kuo, H.T. Chao et al. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J. Clin. Endocrinol. Metab. 85, 597\u2013600 (2000). https:\/\/doi.org\/10.1210\/jcem.85.2.6367","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3747_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/cge.12153","volume":"84","author":"A Phedonos","year":"2013","unstructured":"A. Phedonos, C. Shammas, N. Skordis et al. High carrier frequency of 21-hydroxylase deficiency in Cyprus. Clin. Genet. 84, 585\u2013588 (2013). https:\/\/doi.org\/10.1111\/cge.12153","journal-title":"Clin. Genet."},{"key":"3747_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/jc.2004-1728","volume":"90","author":"SM Baumgartner-Parzer","year":"2005","unstructured":"S.M. Baumgartner-Parzer, P. Nowotny, G. Heinze et al. Carrier Frequency of Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in a Middle European Population. J. Clin. Endocrinol. Metab. 90, 775\u2013778 (2005). https:\/\/doi.org\/10.1210\/jc.2004-1728","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3747_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/JPEM.2001.14.1.27","volume":"14","author":"R Mathur","year":"2001","unstructured":"R. Mathur, P.S.N. Menon, M. Kabra et al. Molecular characterization of mutations in Indian children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J. Pediatr. Endocrinol. Metab. 14, 27\u201335 (2001). https:\/\/doi.org\/10.1515\/JPEM.2001.14.1.27","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"3747_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4103\/2230-8210.95679","volume":"16","author":"E Marumudi","year":"2012","unstructured":"E. Marumudi, A. Sharma, B. Kulshreshtha et al. Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia. Indian J. Endocrinol. Metab. 16, 384\u2013388 (2012). https:\/\/doi.org\/10.4103\/2230-8210.95679","journal-title":"Indian J. Endocrinol. Metab."},{"key":"3747_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cca.2016.11.037","volume":"464","author":"R Khajuria","year":"2017","unstructured":"R. Khajuria, R. Walia, A. Bhansali, R. Prasad, The spectrum of CYP21A2 mutations in Congenital Adrenal Hyperplasia in an Indian cohort. Clin. Chim. Acta 464, 189\u2013194 (2017). https:\/\/doi.org\/10.1016\/j.cca.2016.11.037","journal-title":"Clin. Chim. Acta"},{"key":"3747_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12020-020-02494-z","volume":"71","author":"P Gangodkar","year":"2021","unstructured":"P. Gangodkar, V. Khadilkar, P. Raghupathy, R. Kumar, A. A. Dayal, D. Dayal, A. Ayyavoo, T. Godbole, R. Jahagirdar, K. Bhat, N. Gupta, Clinical application of a novel next generation sequencing assay for CYP21A2 gene in 310 cases of 21-hydroxylase congenital adrenal hyperplasia from India. Endocrine 71, 189\u2013198 (2021)","journal-title":"Endocrine"},{"key":"3747_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s42000-023-00445-7","volume":"22","author":"A Monteiro","year":"2023","unstructured":"A. Monteiro, P.V. Pavithran, M. Puthukulangara et al. Cost-effective genotyping for classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) in resource-poor settings: multiplex ligation probe amplification (MLPA) with\/without sequential next-generation sequencing (NGS). Hormones 22, 311\u2013320 (2023). https:\/\/doi.org\/10.1007\/s42000-023-00445-7","journal-title":"Hormones"},{"key":"3747_CR25","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"M.I. New, M. Abraham, B. Gonzalez et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA 110, 2611\u20132616 (2013). https:\/\/doi.org\/10.1073\/pnas.1300057110","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3747_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13312-020-1703-3","volume":"57","author":"P Vats","year":"2020","unstructured":"P. Vats, A. Dabas, V. Jain et al. Newborn Screening and Diagnosis of Infants with Congenital Adrenal Hyperplasia. Indian Pediatr. 57, 49\u201355 (2020)","journal-title":"Indian Pediatr."},{"key":"3747_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s13224-015-0712-y","volume":"66","author":"R Kishore Kumar","year":"2016","unstructured":"R. Kishore Kumar, H. Das, P. Kini, Newborn Screening for Congenital Adrenal Hyperplasia in India: What Do We Need to Watch Out for? J. Obstet. Gynaecol. India 66, 415\u2013419 (2016). https:\/\/doi.org\/10.1007\/s13224-015-0712-y","journal-title":"J. Obstet. Gynaecol. India"},{"key":"3747_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-018-2091-8","volume":"18","author":"HG D\u00f6rr","year":"2018","unstructured":"H.G. D\u00f6rr, J. Hess, T. Penger et al. Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency. BMC Pregnancy Childbirth 18, 456 (2018). https:\/\/doi.org\/10.1186\/s12884-018-2091-8","journal-title":"BMC Pregnancy Childbirth"},{"key":"3747_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.982953","volume":"13","author":"X Guo","year":"2022","unstructured":"X. Guo, Y. Zhang, Y. Yu et al. Getting pregnant with congenital adrenal hyperplasia: Assisted reproduction and pregnancy complications. A systematic review and meta-analysis. Front. Endocrinol. 13, 982953 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.982953","journal-title":"Front. Endocrinol."},{"key":"3747_CR30","doi-asserted-by":"publisher","unstructured":"U.D. Rajendran, C. Kamalarathnam, Clinical Profile, Predictors of Death and Anthropometric Follow up in Neonates with Classical 21-Hydroxylase Deficiency. JCDR 2018, https:\/\/doi.org\/10.7860\/JCDR\/2018\/33977.11552","DOI":"10.7860\/JCDR\/2018\/33977.11552"},{"key":"3747_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/NEJMra013182","volume":"348","author":"MJ Khoury","year":"2003","unstructured":"M.J. Khoury, L.L. McCabe, E.R.B. McCabe, Population Screening in the Age of Genomic Medicine. N. Engl. J. Med. 348, 50\u201358 (2003). https:\/\/doi.org\/10.1056\/NEJMra013182","journal-title":"N. Engl. J. Med."},{"key":"3747_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ymgmr.2014.07.002","volume":"1","author":"CN Greene","year":"2014","unstructured":"C.N. Greene, S.K. Cordovado, D.P. Turner et al. Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines. Mol. Genet Metab. Rep. 1, 312\u2013323 (2014). https:\/\/doi.org\/10.1016\/j.ymgmr.2014.07.002","journal-title":"Mol. Genet Metab. Rep."},{"key":"3747_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10508-017-1003-8","volume":"47","author":"HFL Meyer-Bahlburg","year":"2018","unstructured":"H.F.L. Meyer-Bahlburg, J. Khuri, J. Reyes-Portillo et al. Stigma Associated with Classical Congenital Adrenal Hyperplasia in Women\u2019s Sexual Lives. Arch. Sex. Behav. 47, 943\u2013951 (2018). https:\/\/doi.org\/10.1007\/s10508-017-1003-8","journal-title":"Arch. Sex. Behav."},{"key":"3747_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10508-016-0862-8","volume":"46","author":"HFL Meyer-Bahlburg","year":"2017","unstructured":"H.F.L. Meyer-Bahlburg, J.A. Reyes-Portillo, J. Khuri et al. Syndrome-Related Stigma in the General Social Environment as Reported by Women with Classical Congenital Adrenal Hyperplasia. Arch. Sex. Behav. 46, 341\u2013351 (2017). https:\/\/doi.org\/10.1007\/s10508-016-0862-8","journal-title":"Arch. Sex. Behav."},{"key":"3747_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10508-016-0841-0","volume":"46","author":"AA Joseph","year":"2017","unstructured":"A.A. Joseph, B. Kulshreshtha, I. Shabir et al. Gender Issues and Related Social Stigma Affecting Patients with a Disorder of Sex Development in India. Arch. Sex. Behav. 46, 361\u2013367 (2017). https:\/\/doi.org\/10.1007\/s10508-016-0841-0","journal-title":"Arch. Sex. Behav."},{"key":"3747_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/2230-8210.111596","volume":"17","author":"M Eunice","year":"2013","unstructured":"M. Eunice, A.C. Ammini, Prenatal treatment of mothers with fetuses at risk for congenital adrenal hyperplasia: How relevant is it to Indian context? Indian J. Endocrinol. Metab. 17, 373\u2013375 (2013). https:\/\/doi.org\/10.4103\/2230-8210.111596","journal-title":"Indian J. Endocrinol. Metab."},{"key":"3747_CR37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4103\/ijem.IJEM_159_18","volume":"22","author":"SA Dar","year":"2018","unstructured":"S.A. Dar, M. Nazir, R. Lone et al. Clinical Spectrum of Disorders of Sex Development: A Cross-sectional Observational Study. Indian J. Endocrinol. Metab. 22, 774\u2013779 (2018). https:\/\/doi.org\/10.4103\/ijem.IJEM_159_18","journal-title":"Indian J. Endocrinol. Metab."},{"key":"3747_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnbeh.2020.00038","volume":"14","author":"E Daae","year":"2020","unstructured":"E. Daae, K.B. Feragen, A. Waehre et al. Sexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review. Front Behav. Neurosci. 14, 38 (2020). https:\/\/doi.org\/10.3389\/fnbeh.2020.00038","journal-title":"Front Behav. Neurosci."},{"key":"3747_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02715905","volume":"81","author":"AH Bittles","year":"2002","unstructured":"A.H. Bittles, Endogamy, consanguinity and community genetics. J. Genet 81, 91\u201398 (2002). https:\/\/doi.org\/10.1007\/BF02715905","journal-title":"J. Genet"},{"key":"3747_CR40","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1056\/NEJMoa012113","volume":"347","author":"W Burke","year":"2002","unstructured":"W. Burke, Genetic Testing. N. Engl. J. Med. 347, 1867\u20131875 (2002). https:\/\/doi.org\/10.1056\/NEJMoa012113","journal-title":"N. Engl. J. Med."},{"key":"3747_CR41","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"S. Baumgartner-Parzer, M. Witsch-Baumgartner, W. Hoeppner, EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur. J. Hum. Genet 28, 1341\u20131367 (2020). https:\/\/doi.org\/10.1038\/s41431-020-0653-5","journal-title":"Eur. J. Hum. Genet"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03747-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T09:31:37Z","timestamp":1720863097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03747-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["3747"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03747-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"4 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of Christian Medical College, Vellore, India (IRB Min. number: 14042 dated 30.06.2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}